A report from Romanian TV, one year on from the European Parliament cash-for-influence scandal, in English and Romanian.
Published by:
Televiziunea Romana
One year on from cash-for-influence
Similar entries
Industry lobbies step up spin on cash-for-amendments scandal
After the intense debate and media attention in the first weeks after the European Parliament's cash-for-amendments scandal broke, it has become very quiet in the last weeks. Discussions about transparency and ethics reforms in the wake of the scandal take place in secrecy in a working group of ten MEPs, led by Parliament President Buzek, in weekly meetings behind closed doors.
Cash-for-amendments scandal just the tip of the iceberg
New rules needed to curb power of corporate lobbyists in the European Parliament
Cash-for-amendments scandal tip iceberg
New rules needed to curb power of corporate lobbyists in the European Parliament
BP - Extracting Influence in the EU
BP - Extracting influence at the heart of the EU
An Introduction
An Introduction
Big Pharma spends over €40 million per year lobbying in the EU, dwarfing public health NGOs
28 March 2012 - New research reveals that the pharmaceutical industry lobby is spending more than €40 million annually to influence decision making in the European Union (EU) – of which nearly half is spent by drug manufacturers on in-house lobbyists.
According to these findings, civil society organisations active on EU medicines issues, on the other hand, spend a combined €3.4 million per year. With the immense disparity between the affluence of public interest groups and the industrial lobby, it becomes even more difficult to level the policy playing field.
Pages
Corporate Europe Observatory
Corporate Europe Observatory (CEO) is a research and campaign group working to expose and challenge the privileged access and influence enjoyed by corporations and their lobby groups in EU policy making.
All content on this website is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.